+43-123-13-985|info@ces.b2sg.org
Clinical 2017-05-19T11:28:21+00:00
Welcome to the Cancer Epigenetics Drug Database, Clinical section which consists of a repository of most (if not all) cancer clinical trials employing epigenetic drugs, including inhibitors of DNA methyltransferases (DNMTi), histone deacetylases (HDACi), histone methyltransferases (HMTi), and histone lysine demethylases (KDMi). We will cover additional cancer epigenetic drugs in the near future. Please click on the desired class of epigenetic enzymes depicted below on the nuclesomes to open the corresponding database.